PTGS2 and cancer: Potential effect of IL-4 and IL-13 (250 ng/mL, 24 h) on the expression of genes encoding proteins relevant for cancer development by facilitating angiogenesis (HIF1A and VEGFA), inflammation (PTGS2, NOS2, CCL2), and metabolic reprogramming (GLUT1, ODC1, NOS2) was evaluated.